Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 전원배 | - |
dc.contributor.author | 이경민 | - |
dc.contributor.author | 김정희 | - |
dc.date.accessioned | 2021-04-23T05:36:24Z | - |
dc.date.available | 2021-04-23T05:36:24Z | - |
dc.identifier.uri | http://hdl.handle.net/20.500.11750/13270 | - |
dc.description.abstract | The present invention relates to a pharmaceutical composition for treating diabetes, which includes a pancreatic islet cell and an elastin-like artificial extracellular matrix (REP), and more particularly, to a pharmaceutical composition for treating diabetes, in which pancreatic islet cells are reacted with an elastin-like artificial extracellular matrix and then the resulting cells are administered along with the elastin-like artificial extracellular matrix, thus increasing a survival rate of the transplanted pancreatic islet cells, rapidly restoring a blood glucose level to normal, and maintaining the restored blood glucose level for a long period of time, and, accordingly, diabetes may be more effectively treated. | - |
dc.title | 췌장소도세포 및 엘라스틴 유사 인공 세포외 기질을 포함하는 당뇨병 치료용 약학적 조성물 | - |
dc.title.alternative | PHARMACEUTICAL COMPOSITION FOR TREATING DIABETES, COMPRISING PANCREATIC ISLET CELLS AND ELASTIN-LIKE ARTIFICIAL EXTRACELLULAR MATRIX | - |
dc.type | Patent | - |
dc.publisher.country | US | - |
dc.identifier.patentApplicationNumber | 15-773496 | - |
dc.date.application | 2018-05-03 | - |
dc.identifier.patentRegistrationNumber | 10-813954 | - |
dc.date.registration | 2020-10-27 | - |
dc.contributor.assignee | (재)대구경북과학기술원(100/100) | - |
dc.type.iprs | 특허 | - |
There are no files associated with this item.